Sastasundar Ventures Ltd - 533259 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2019
Please find attached herewith the Certificate under Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 from Practicing Company Secretary for the half year ended 31st March, 2019 Sastasundar Ventures Ltd - 533259 - Shareholding for the Period Ended March 31, 2019
Sastasundar Ventures Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Sastasundar Ventures Ltd - 533259 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (LODR) Reg, 2015 For The Half Year Ended 31St March, 2019
Enclosed please find attached herewith the Compliance Certificate pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015 for the half year ended 31st March, 2019 for your records and reference. Sastasundar Ventures Ltd - 533259 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- BIPLAB KUMAR MANIDesignation :- Company Secretary and Compliance Officer Sastasundar Ventures Ltd - 533259 - Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 With Respect To Completion Of Transfer Of Genu Path Labs Limited
In continuation of earlier intimation dated 5th March, 2019, we would like to inform you that the entire stake held by the Company in Genu Path Labs Limited has been transferred on 9th April, 2019 to Sastasundar Healthbuddy Limited, a subsidiary of the Company. . This is for your information and records. Sastasundar Ventures Ltd - 533259 - Closure of Trading Window
Pursuant to the Clause 4 of the schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015 ('the Regulations') as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and clarification issued by NSE vide its circular No: NSE/CML/2019/11 dated 02.04.2019 and BSE vide its circular No. LIST/COMP/01/2019-20 dated 02.04.2019; the Trading Window for trading in the securities of the Company will remain closed for ''Designated Persons'' with immediate effect till 48 hours after the announcement of the financial results of the Company for the quarter and year ended on March 31, 2019. The date of the Board meeting for approval of financial results for the above mentioned period shall be intimated in due course. Kindly take note of the same. Sastasundar Ventures Ltd - 533259 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company through circular resolution on 01.04.2019, has, inter alia, approved, based on the recommendations of Nomination & Remuneration Committee, CS (Dr.) Saibal Chandra Pal (DIN-00518330) as an Additional Director (Independent) w.e.f. 1st April, 2019 subject to the approval of the shareholders at the ensuing AGM of the Company. The Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The details as per Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09.09.2015 is enclosed herewith as Annexure-A. Intimation pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (LODR) Reg, 2015 is given that the term of Mr. R N Bhardwaj (DIN-01571764) and Mr. Deba Prasad Roy (DIN-00049269) as an Independent Directors expired on 31.03.2019 and they are not being re-appointed as an Independent Director in the Company. Sastasundar Ventures Ltd - 533259 - Intimation Under SEBI {Prohibition Of Insider Trading) Regulations, 2015
Pursuant to Regulation 8(2) of the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, we hereby inform you that the Board of Directors of the Company by circular resolution passed on March 29, 2019 has, inter alia, approved the revised 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information and that the amendments shall be effective from 1st April, 2019. The said revised Code is attached as "Annexure A" and is also being disseminated on the official website of the Company at www.sastasundarventures.com. Kindly take the above intimation on record and kindly acknowledge the receipt of the same. Sastasundar Ventures Ltd - 533259 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
We would like to inform you that Sastasundar Ventures Limited (the Company) has signed a Share Purchase Agreement ( ''the Agreement'') today i.e. 5th March, 2019 with Sastasundar Healthbuddy Limited, a subsidiary Company (the Acquirer), to sell and transfer the entire stake held by the Company in Genu Path Labs Limited, a wholly owned subsidiary company. The details as required under regulation 30 of the SEBI Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 are given in Annexure -A to this letter. Sastasundar Ventures Ltd - 533259 - Update To Disclosure On January 29, 2019 By Sastasundar Ventures Limited (The 'Company") & Notice Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Update to disclosure on January 29, 2019 by Sastasundar Ventures Limited (the 'Company") & Notice pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015